Organoid Therapeutics (formerly known as ECMedical Inc.) develops organoid-based technologies for healthcare applications. The company provides lab-grown artificial organ technologies designed to correct hormone deficiencies and support drug discovery and toxicology testing. Its solutions are used in both clinical and research settings, enabling more accurate disease modeling and therapeutic development. Organoid Therapeutics leverages advanced cell culture and engineering techniques to create functional organoids that mimic human organ systems. These technologies facilitate the development and testing of new drugs, as well as regenerative medicine approaches. The company serves pharmaceutical companies, research institutions, and clinical laboratories focused on innovative healthcare solutions.